Key facts
- ElectraDx’s last known valuation is $292.0M (Nov 2025).
- It has raised $46.8M across 1 recorded rounds; the latest was Early Stage VC ($14.8M) in Feb 2024.
- Notable investors include TAUNS Laboratories.
- ElectraDx has filed 2 Form Ds with the SEC, most recently Mar 2024 ($14.8M sold to 22 investors).
- Status: Privately Held (backing).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ElectraDx
Create free account
No card required
Funding rounds
1 roundsAbout ElectraDx
The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2023
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
ElectraDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in ElectraDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on ElectraDx in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.